[Urine specimens in diagnosing chlamydia in women]

The Swedish Council on Health Technology Assessment
Record ID 32010000468
English, Swedish
Authors' recommendations: Urine specimens are somewhat less sensitive (ie, miss more cases) than vaginal and cervical specimens. Vaginal specimens have the highest sensitivity for diagnosing chlamydia in women.Urine, vaginal, and cervical specimens have similar specificity. In other words, they are equally likely to yield a correct, ie, negative, finding in women who are not infected.The scientific evidence is insufficient to compare the diagnostic accuracy of urine specimens alone versus various combinations of specimens, since only one study in the assessment included such a comparison.The scientific evidence is insufficient to draw conclusions on the cost-effectiveness of using urine specimens as the only test for establishing a chlamydia diagnosis in women. Too few studies of sufficient quality are available. The total cost of chlamydia testing is influenced mainly by how specimens are taken. Vaginal and urine specimens can be collected by the patient herself. This lowers the cost in comparison to taking cervical specimens, where health professionals must collect the specimen.
Details
Project Status: Completed
URL for project: www.sbu.se/201005e
Year Published: 2010
URL for published report: www.sbu.se/201005
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Sweden
MeSH Terms
  • Chlamydia
  • Chlamydia Infections
  • Chlamydia trachomatis
  • Mass Screening
  • Predictive Value of Tests
  • Sensitivity and Specificity
  • Urine
Contact
Organisation Name: Swedish Agency for Health Technology Assessment and Assessment of Social Services
Contact Address: P.O. Box 3657, SE-103 59 Stockholm, Sweden. Tel: +46 8 4123200, Fax: +46 8 4113260
Contact Name: registrator@sbu.se
Contact Email: registrator@sbu.se
Copyright: The Swedish Council on Health Technology Assessment (SBU)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.